The second delisting notice and deeply dilutive warrant exchange signal imminent equity restructuring or potential bankruptcy. The warrants' 30% discount to VWAP and nominal exercise price guarantee near-term selling pressure if Indigo exercises and sells. Monitor for further NYSE American actions, additional preferred exchanges, and any going-concern disclosure in the next 10-Q.
Price Chart
Executive Summary
Nuburu, Inc. received a second NYSE American delisting notice on May 12, 2026, for failing to maintain $4.0M in stockholders' equity (deficit of ~$15.2M as of Dec 31, 2025). To address this, the company entered an exchange agreement with Indigo Capital LP, issuing pre-funded warrants exercisable for up to 4,398,399 common shares at a nominal price in exchange for 71,430 Series A Preferred shares. The combination of a deepening equity deficit, a second listing standard violation, and highly dilutive warrant issuance signals severe financial distress.
Key Facts
- Received second NYSE American delisting notice on May 12, 2026 for violating Section 1003(a)(ii) — stockholders' equity below $4.0M with losses in 3 of 4 fiscal years
- Stockholders' deficit of approximately $15.2 million as of December 31, 2025
- Entered exchange agreement with Indigo Capital LP on May 11, 2026 to exchange up to 446,946 Series A Preferred shares for pre-funded warrants
- Initial closing: 71,430 Series A Preferred shares exchanged for a warrant exercisable for up to 4,398,399 common shares at $0.0001 per share
- Warrant exercise price is nominal ($0.0001/share); share count determined by lowest VWAP over 5 prior trading days discounted by 30%
- Warrant exercisable immediately for 3 years until May 11, 2029; includes 4.99% beneficial ownership blocker
- Prior S-3/A and S-3 filings (within 8 and 21 days) registered up to 60M shares for resale by YA II PN, LTD under a SEPA facility
- Company previously received a 2025 delisting notice under Section 1003(a)(i) and was granted a compliance plan through October 29, 2026
Financial Impact
Stockholders' deficit of ~$15.2M; warrant issuance could result in up to 4,398,399 new common shares at near-zero exercise price, representing massive dilution relative to current outstanding shares
Risk Factors
- Actual delisting from NYSE American if compliance plan fails, severely reducing liquidity and institutional ownership
- Massive dilution from up to 4.4M warrant shares at near-zero exercise price, potentially flooding the market
- Stockholders' deficit of $15.2M indicates negative book value and potential insolvency risk
- Dual-track capital raise (S-3 shelf + warrant exchange) suggests desperate financing needs
- Loss of patent portfolio through foreclosure (mentioned in risk factors) further weakens asset base
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-227202 |
| Document: 0001193125-26-227202-index-headers.html | 0001193125-26-227202 |
| Document: 0001193125-26-227202-index.html | 0001193125-26-227202 |
| Document: 0001193125-26-227202.txt | 0001193125-26-227202 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 9, 2026 19w ago | 8-K | — | awaiting T+20 | — | — |
May 15, 2026 23w ago | 8-K | — | awaiting T+20 | — | — |
May 13, 2026 23w ago | EFFECT | — | awaiting T+20 | — | — |
May 7, 2026 24w ago | S-3/A | — | awaiting T+20 | — | — |
Apr 28, 2026 25w ago | 10-K/A | — | awaiting T+20 | — | — |
Apr 24, 2026 26w ago | S-3 | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers